BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11460570)

  • 1. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.
    Kraegen EW; Cooney GJ; Ye JM; Thompson AL; Furler SM
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S189-201. PubMed ID: 11460570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids and insulin resistance in muscle and liver.
    Kovacs P; Stumvoll M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
    Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
    Blaak EE
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature.
    Krebs M; Roden M
    Diabetes Obes Metab; 2005 Nov; 7(6):621-32. PubMed ID: 16219006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes mellitus and skeletal muscle metabolic function.
    Phielix E; Mensink M
    Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity.
    Horowitz JF
    Exerc Sport Sci Rev; 2007 Oct; 35(4):192-6. PubMed ID: 17921788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into fatty acid modulation of pancreatic beta-cell function.
    Haber EP; Procópio J; Carvalho CR; Carpinelli AR; Newsholme P; Curi R
    Int Rev Cytol; 2006; 248():1-41. PubMed ID: 16487789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
    Corpeleijn E; Saris WH; Blaak EE
    Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intramuscular lipid in insulin resistance.
    Hegarty BD; Furler SM; Ye J; Cooney GJ; Kraegen EW
    Acta Physiol Scand; 2003 Aug; 178(4):373-83. PubMed ID: 12864742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].
    Gries FA; Hübinger A
    Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
    Boden G
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.